Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionCH24H inhibitor
Molecular Target Cytochrome P450 family 46 subfamily A polypeptide 1 (CYP46A1) (CH24H)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Neurology (unspecified)
Indication DetailsTreat diseases related to glutamate excitotoxicity
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today